Eliav Shaked

Eliav Shaked, co-founder of RetiSpec, is pioneering the use of AI-driven retinal imaging for early Alzheimer's detection. He discusses the importance of accessible diagnostic tools, revealing how a simple eye exam can identify amyloid burden. Eliav highlights breakthroughs in Alzheimer's medications and predicts more advancements for early-stage treatments. He emphasizes that technology will transform healthcare, paving the way for better care and early diagnosis of neurodegenerative diseases.